28 April 2017 - Treatments approved by David Cameron’s scheme were not worth money, extended life very little and often had ...
3 October 2016 - This article reviews the means by which the Cancer Drugs Fund made recent funding decisions for cancer ...
27 September 2016 - Reliance on “real world” observational data undermines evidence base for clinical practice. ...
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
10 August 2016 - The drug brentuximab vedotin may no longer be provided on the NHS. ...
29 July 2016 - England's Cancer Drugs Fund reopens under its new model today, but the pharma industry and charities are ...
14 June 2016 - The UK National Health Service, like most other developed health care systems, has struggled with how to ...
8 June 2016 - Over the past five years thousands of patients in England have been given access to new but ...
16 May 2016 - Fifteen cancer charities have said they are "deeply concerned" about new plans for approving innovative cancer medicines ...
16 March 2016 - Proposals will see new clinically and cost effective cancer drugs approved for use on the NHS earlier ...
7 March 2016 - The reincarnation of the Cancer Drugs Fund will benefit both NICE and the NHS. ...
29 February 2016 - NHS England has confirmed that from 1 July its Cancer Drugs Fund will operate on a “managed ...
26 February 2016 - The ABPI is disappointed by today's decision by NHS England that it will continue to push ahead ...
11 February 2016 - Erik Nordkamp, managing director of Pfizer UK, said England already had one of the poorest outcomes for ...
11 February 2016 - Ministers have less than two months to thrash out a new system for financing cancer drugs in ...